摘要
目的观察复聪汤加减治疗儿童分泌性中耳炎(SOM)合并阻塞型睡眠呼吸暂停低通气综合征(OSAHS)的疗效及安全性。方法 120例患者随机分为对照组和观察组,各60例。对照组给予头孢丙烯+欧龙马+孟鲁司特钠+糠酸莫米松,观察组在对照组治疗基础上给予复聪汤加减,疗程均为60 d。采用放射免疫法检测血清中谷胱甘肽过氧化物酶(GSH-Px)、人表皮生长因子(hEGF)、降钙素基因相关肽(CGRP)和内皮素-1(ET-1)的含量;采用流式细胞术微球阵列法检测血清中肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)和白细胞介素-10(IL-10)的含量;连续7 h监测呼吸暂停低通气指数(AHI)和阻塞型睡眠呼吸暂停低通气18项指标(OSA-18)量表;观察脾虚痰湿证中医证候评分、有效率和不良反应发生率。结果研究期间脱落4例。观察组患儿总有效率89.8%,高于对照组的75.4%(P<0.05);观察组患儿AHI、OSA-18和中医证候改善程度优于对照组(P<0.05);观察组患儿血清中GSH-Px、hEGF、CGRP和ET-1水平改善程度优于对照组(P<0.05);观察组患儿不良反应发生率1.7%,低于对照组的15.8%(P<0.05)。结论复聪汤加减可明显改善SOM合并OSAHS患儿的临床症状,不良反应发生率低,值得临床推广应用。
OBJECTIVE To observe the efficacy and safety of modified Fucong decoction in treating children secretory otitis media(SOM) with obstructive sleep apnea and hypopnea syndrome(OSAHS). METHODS 120 patients were randomly divided into the control group and the observation group, each including 60 cases respectively. The control group was treated with Cefprozil + Olongma + Montelukast Sodium + Mometasone Furoate Nasal Spray. The observation group was treated with modified Fucong decoction on the basis of the treatment in the control group. Both of them have a 60-day-course. The contents of glutathione peroxidase(GSH-Px), human epidermal growth factor(hEGF), calcitonin gene-related peptide(CGRP) and endothelin-1(ET-1) in serum were detected by radioimmunoassay. The project also resorted to cytometric bead array to detect the levels of tumor necrosis factor-α(TNF-α), interleukin-1β(IL-1β), interleukin-6(IL-6) and interleukin-10(IL-10) in serum. The apnea hyponea index(AHI) and 18 indexes of obstructive sleep apnea(OSA-18) were monitored for 7 consecutive hours. The project observed TCM syndrome grades of spleen-deficiency phlegm-dampness syndrome, as well as the effective rate and adverse reaction rates of the two groups. RESULTS There were 4 cases of abscission. The total effective rate in the observation group was 89.8%, higher than that in the control group, 75.4%(P<0.05). AHI, OSA-18 and TCM syndromes in the observation group improved much more significantly than those in the control group(P<0.05). The serum levels of GSH-Px, hEGF, CGRP and ET-1 of the observation group improved much more significantly than those in the control group(P<0.05). The incidence of adverse reactions was 1.7% in the observation group, lower than 15.8% in the control group(P<0.05). CONCLUSION Modified Fucong decoction can significantly improve the clinical symptoms of SOM with OSAHS and the incidence of adverse reactions is low, which is worthy of clinical application.
引文
[1] ASBJORN KH,ANDERS K,JORGEN L,et al.Risk of childhood otitis media with focus on potentially modifiable factors:A Danish follow-up cohort study[J].Int J Pediatr Otorhinolaryngol,2018,106(4):1-9.
[2] SON MJ,KIM YE,SONG YI,et al.Herbal medicines for treating acute otitis media:A systematic review of randomised controlled trials[J].Complement Ther Med,2017,35(12):133-139.
[3] 文凤妮,黄文柱,陆扬光,等.龙胆泻肝胶囊对肝胆湿热型分泌性中耳炎患者PAF,ET-1含量的影响[J].中国实验方剂学杂志,2016,22(10):158-161.
[4] DAI ZY,HUANG DY,ZHOU CY,et al.Effects of partial tonsillectomy on the immune functions of children with obstructive sleep apnea-hypopnea syndrome at early stage[J].Genet Mol Res,2014,13(2):3895-3902.
[5] 王秉权,崔伟锋.治肺通耳合剂对慢性分泌性中耳炎患者听功能的影响[J].世界中西医结合杂志,2018,13(9):1283-1285,1313.
[6] QUADRI F,BONI E,PINI L,et al.Exercise tolerance in obstructive sleep apnea-hypopnea (OSAH),before and after CPAP treatment:Effects of autonomic dysfunction improvement [J].Respir Physiol Neurobiol,2017,236(2):51-56.
[7] 江载芳,申昆玲,沈颖.诸福棠实用儿科学[M].8 版.北京:人民卫生出版社,2015:1247-1251.
[8] 肖全成.中医对鼾症的认识和诊疗概况[J].柳州医学,1994(1):27-28.
[9] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:人民卫生出版社,1993:129-132.
[10] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉科学分会.儿童阻塞性睡眠呼吸暂停低通气综合征诊疗指南草案(乌鲁木齐)[J].中华耳鼻咽喉头颈外科杂志,2007,42(2):83-84.
[11] RUTH BT,LEA-ANN SK,KARLI JC,et al.No evidence for impaired humoral immunity to pneumococcal proteins in Australian Aboriginal children with otitis media[J].Int J Pediatr Otorhinolaryngol,2017,92(5):119-125.
[12] URQUHART D.Investigation and management of childhoodsleep apnoea[J].Hippokratia,2013,17(3):196-202.
[13] HERMANUS CM,STACY J,De WS,et al.Towards low cost automated smartphone- and cloud-based otitis media diagnosis[J].Biomed Signal Process Control,2018,39(6):34-52.
[14] 康一,谈晓文,朱丽烨,等.鼓膜穿刺和鼓膜激光打孔及鼓膜置管在治疗儿童分泌性中耳炎中的疗效比较[J].临床耳鼻咽喉头颈外科杂志,2018(22):1723-1727.
[15] 巢元方.诸病源候论:卷三十一[M].北京:人民卫生出版社,1955:163.
[16] 张山雷.小儿药证直诀笺要[M].上海:上海科学技术出版社,1958:15.
[17] 方广.丹溪心法附余[M].北京:中国中医药出版社,2015:834.
[18] AMELLE L,CYRILLE T,ELODIE D,et al.Dentoskeletal sequellae after wearing of a mandibular advancement device in an OSAHS setting[J].Int Orthod,2017,15(2):251-262.
[19] 赵源庆,郭家亮,唐慧玲.鼻内镜下腺样体切除联合鼓室置管治疗儿童阻塞性睡眠呼吸暂停低通气综合征伴分泌性中耳炎[J].中国内镜杂志,2014,20(3):302-305.
[20] 邹家全,雷小青,黄永贵,等.儿童OSAHS合并分泌性中耳炎216例临床分析[J].中国医药导刊,2013,15(5):768-770.
[21] ZHANG HN,YANG F,GUO YC,et al.The contribution of chronic intermittent hypoxia to OSAHS:From the perspective of serum extracellular microvesicle proteins[J].Metabolism,2018,85(8):97-108.
[22] 吴皓,吕静荣.小儿耳鼻咽喉科学的历史与进展[J].中国医学文摘(耳鼻咽喉科学),2013,28(1):2-4.
[23] TAGAYA M,NAKATA S,YASUMA F,et al.Children with se-vere or moderate obstructive sleep apnoea syndrome show a high incidence of persistence after adenotonsil-lectomy[J].Acta Otolaryngol,2012,132(11):1208-1212.
[24] JAROSIEWICZ M,KROKOSZ A,MARCZAK A,et al.Changes in the activities of antioxidant enzymes and reduced glutathione level in human erythrocytes exposed to selected brominated flame retardants[J].Chemo,2019,227(5):93-99.
[25] AROUSA F,BOIVINA JM,CHAOUATC A,et al.Awareness of obstructive sleep apnea-hypopnea syndrome among the general population of the Lorraine Region of France[J].Eur Ann Otorhinolaryngol Head Neck Dis,2017,134(5):303-308.
